Toray Of Japan, Kyoto University Develop Patient-Specific Breast-Cancer Test
This article was originally published in PharmAsia News
Executive Summary
Japan’s Toray Industries has joined with Kyoto University to develop a test to determine if Genentech’s Herceptin (trastuzumab) for treating breast cancer would be an effective treatment for certain patients.